Press Center

Drsignal Biotech collaborates with J&V Energy to jointly create a green energy future

Global Decarbonization Initiatives Accelerate: J&V Energy Seizes Carbon free Opportunity, Forging Cross-Industry Collaboration. On the 27th of this month, J&V Energy joined forces with Drsignal Biotech at the '2023 Asia Biotech Expo' to host the 'Energy & Biotech Dual Fusion Project Signing Ceremony.' The collaboration marks a milestone in the cross-sector partnership between the green energy and biotech industries. In the future, CO2 generated from biomass power generation will be refined using exclusive positive and negative carbon conversion technology to produce refined green carbon dioxide for use in biotech laboratories, offering a novel solution for waste resource utilization and achieving the world's first net-zero circular technology!

Mr. Tan ,Deputy General Manager of J&V Energy, emphasized the significance of this collaboration for the green energy industry. While renewable energy effectively reduces CO2 emissions, industrial activities unavoidably produce carbon emissions. Through this collaboration, CO2 waste will be transformed into a valuable source for high-end biotechnology and stem cell cultivation technology, setting a global benchmark in circular technology. This innovative approach provides a fresh solution for governments and businesses worldwide to overcome 'carbon anxiety,' truly achieving net-zero circular goals and ushering in a new era of green energy.

The green CO2 provided by J&V Energy for this collaboration is refined from exhaust gases produced by the biomass fuel power plant invested by the group in Pingtung. This plant is Taiwan's first biomass fuel power plant utilizing agricultural residues for power generation. It is also committed to carbon capture, refining, and reuse, establishing Taiwan's first green CO2 circular biomedical center.

At the 2023 Asia Biotech Expo, Drsignal Biotech and J&V Energy unveiled the positive and negative carbon conversion technology, offering a groundbreaking solution for global governments and businesses to address 'carbon anxiety.' With the theme of 'Green Power•Golden Bio,' this collaboration heralds the dawn of Taiwan's golden age in the biotech industry, leading the dual industries of biotechnology and green energy to flourish.

Dr. Mi, Chairman of Drsignal Biotech, pointed out that Taiwan's biotech industry has achieved remarkable results through long-term efforts. According to recent reports, the operating revenue of Taiwan's biomedicine industry has risen from NT$421.5 billion in 2015 to NT$591.3 billion in 2020. What's even more pleasing is that it surpassed the trillion-dollar market value in 2015 and did so again in 2020, indicating the potential for the biotech industry to develop into a two-trillion-dollar sector.

The key to achieving this goal lies in the leadership of CDMO, indicating that the entire CDMO business model will become a trend in the future and bringing unprecedented development opportunities to Taiwan's biotech industry.

Dr. Mi noted that Drsignal Biotech successfully demonstrated the remarkable 3A-GTP technology, which accelerates the popularization of stem cell therapy, achieves mass production of stem cells, and provides Taiwan's unique quantification and standardization of cell processes, paving a new path for regenerative medicine.

He said that the world is facing the threat of climate change, with over 130 countries proposing the '2050 Net-Zero Emissions' goal. Drsignal Biotech has taken the lead in carbon inventory of cell preparation processes, identifying consumables as carbon emission hotspots, resulting in significant CO2 emissions. With the 3A-GTP cell preparation technology, passive carbon reduction of 849 kg CO2e per month is achieved, demonstrating that the cell preparation process requires dozens to hundreds of times more CO2 than produced by gas. Active carbon reduction is about 800 kg CO2e per month, equivalent to the amount of CO2 consumed by approximately 1000 mature trees planted in Taiwan.

Furthermore, the purified CO2 from exhaust gases (green CO2) can be used for cell preparation or any industry that requires CO2, such as carbonated beverages, representing a future trend. Dr. Mi advocates for the use of green CO2 sources to address global carbon anxiety and contribute to sustainable development worldwide.